定开基金

Search documents
建信北证50指数基金发售在即!刘明辉独挑大梁能否驶向星辰大海
Sou Hu Cai Jing· 2025-07-12 04:46
7月11日,建信基金发布《建信北证50成份指数型发起式证券投资基金招募说明书》,这份长达百页的文件,不仅宣告了一只全新指数基金的 即将诞生,更成为建信基金北交所市场化进程中迈出的关键一步。公告内容显示,该基金将于7月15日至7月25日公开发售,以不低于90%的股 票仓位紧密跟踪北证50指数,同时,基金管理费率为0.5%/年,托管费率为0.1%/年。 北证50指数何以吸引资金竞逐?相较于主板和科创板,北交所更注重服务"专精特新"企业,这类企业虽然体量较小,但技术壁垒高、成长潜力 大。因此,众多基金公司纷纷设立北证50成份指数基金。截至2025年一季度末,跟踪北证50的公募基金规模达91.25亿元,成为资金追捧的重 要对象。 北交所首秀 建信北证50成份指数基金拟任基金经理为刘明辉。刘明辉,北京大学应用统计专业硕士,2015年7月毕业,同年7月加入建信基金,历任金融工 程及指数投资部助理研究员、研究员兼投资经理助理、投资经理、基金经理。自2021年10月27日起,刘明辉便与叶乐天开始共同管理建信精工 制造指数增强基金;2022年10月,刘明辉又与薛玲共同承担起管理建信恒生科技指数发起式基金的重任;到2022年12 ...
公募“中考”:医药、北交所主题基金霸榜前十 银河君荣I份额垫底
Zhong Guo Jing Ying Bao· 2025-07-04 19:12
Group 1: Fund Performance Overview - Public funds' performance in the first half of the year shows that pharmaceutical-themed funds and North Exchange-themed funds performed the best, with the top two funds being Huatai-PineBridge Hong Kong Advantage Select Fund C and A shares, yielding 86.68% and 86.48% respectively [1] - Six out of the top ten active equity funds are pharmaceutical-themed, with Changcheng Pharmaceutical Industry Select Fund A and C shares achieving returns of 75.18% and 74.73%, ranking third and fourth [2] - The North Exchange-themed funds also performed well, with CITIC Securities North Exchange Select Fund A/C achieving over 80% returns, making it the highest-yielding active equity fund [2] Group 2: Investment Strategies and Market Trends - The strong performance of pharmaceutical-themed funds is attributed to the innovative drug market, focusing on companies with disruptive innovations and those with products entering commercialization [2] - The North Exchange market benefits from its thematic positioning and overall market uptrend, with high volatility providing trading opportunities [3] - Analysts note that the small-cap style, represented by the North Exchange, aligns with market trends, with sectors like artificial intelligence and robotics driving stock price increases [4] Group 3: Underperforming Funds - The Galaxy Junrong Fund I shares had the worst performance among active equity funds, with a decline of 37.89% in the first half of the year, and also showed poor long-term performance [5] - The fund manager's preference for resource and traditional consumer stocks has led to significant underperformance, with the fund's assets shrinking dramatically due to large redemptions [8] - Several funds under the Caitong brand also ranked poorly, with significant adjustments in holdings reflecting a shift away from overseas computing power stocks to domestic ones [9][10] Group 4: Fund Manager Analysis - The fund manager of Galaxy Junrong has shown a high concentration in specific sectors, which has resulted in unstable performance due to market fluctuations [12] - Caitong's fund manager has shifted focus to domestic computing power, anticipating growth in AI-related investments, but faces challenges due to reliance on imported high-end chips [10][11] - The analysis indicates that the fund manager's strategy of high concentration and frequent sector rotation has led to inconsistent annual returns [11][12]
上半年医药主题基金业绩亮眼 主动权益类前十占六席
Zhong Guo Jing Ying Bao· 2025-07-02 12:01
Group 1 - The top-performing fund in the first half of 2025 is the Huatai-PineBridge Hong Kong Advantage Selected Fund C share, with a return of 86.68% [1] - The second-ranked fund is the A share of the same Huatai-PineBridge fund, achieving a return of 86.48% [1] - Among actively managed equity funds (excluding QDII), the top performers are CITIC Securities North Exchange Selected Two-Year Open Fund A and C shares, with returns of 82.45% and 82.1% respectively [1] Group 2 - Six out of the top ten actively managed equity funds by performance in the first half of 2025 are themed around pharmaceuticals, indicating strong sector performance [1] - The worst-performing fund in the bottom ten is the Galaxy Junrong Fund I share, with a return of -37.89% [2] - Other poorly performing funds include the Qianhai Kaiyuan Artificial Intelligence Fund A share, with a return of -20.57%, and several funds from the Caitong family ranking among the bottom [2]
“冠军”涨超85%,上半年基金业绩排行揭晓
华尔街见闻· 2025-07-02 10:27
以下文章来源于资本深潜号 ,作者资本深潜号 资本深潜号 . 专注资本背后的硬核故事 作者佳飔 编辑袁畅 2025年是对基金投资而言,难度格外大的一年。 这一年机会很多,挑战也很多。AI、机器人、半导体、大模型等主题基金各领风骚,医药、新消费等也各领潮头一段时间。 截至6月30日晚间披露的基金净值,今年上半年表现最为突出的基金前五名包括中, 汇添富香港优势精选、中信建投北交所精选两年定开基金,长城医药产业 精选基金、华夏北交所创新中小企业精选和中银港股通医药基金, 上述产品的净值收益率都超过了70%。 紧随其后的第六到第十名分别是 永赢医药创新智选、广发成长领航一年持有、华安医药生物、平安核心优势、诺安精选价值 ,上述基金的收益率也都超过 61%。 这十只风格各异,投资重点迥然不同的基金成为了业内的领跑军团,充分说明了,2025年以来内地资本市场的热点纷呈和行情莫测的特点交织。 在这样的时代里,能够令基金业绩排名靠前,都不是一般的投资人才。 | 证券商称 | ×间: 大层 [区间首日] 本年初 | | --- | --- | | | [×同居日] 2025-6-30 [单位] %↓ | | arif50 | 3 ...
创新药主题基金一马当先 有望拿下半程冠军
Zheng Quan Shi Bao· 2025-06-29 18:00
Group 1 - The core viewpoint of the articles highlights the strong performance of innovation drug-themed funds, with the Huatai-PineBridge Hong Kong Advantage Select Fund leading the pack with a return of 89.15% as of June 29, 2023 [2][3] - A total of 40 funds have achieved a return exceeding 50% this year, with 16 out of the top 20 funds being innovation drug-themed [2][3] - The AI-themed funds have underperformed significantly, with losses exceeding 20% for the bottom-performing funds [1][3] Group 2 - The active equity funds have generally shown a recovery in performance, with nearly 80% of active equity funds achieving positive returns this year, and over 1,000 funds seeing net value increases of over 10% [4][5] - The market has experienced structural volatility, with different themes impacting fund performance directly, necessitating precise market timing from fund managers [3][4] - The long-term performance of the Huatai-PineBridge North Exchange Innovation Small and Medium Enterprises Select Fund has yielded a cumulative return of 177.04% over the past three years, significantly outperforming its peers [3] Group 3 - The innovation drug sector is currently experiencing a surge, with funds in this category dominating the performance rankings, while the humanoid robot sector has seen a decline from its previous highs [2][7] - The market outlook for the second half of the year suggests a mix of opportunities and risks, with low overall valuation levels and supportive macroeconomic policies being key factors [8][9] - Key investment areas identified include dividend assets, technology sectors with strong policy support, and high-potential domestic demand sectors [9]
上百只,创新高!
中国基金报· 2025-06-25 00:27
【导读】 百余只 主动权益基金净值创历史新高 中国基金报记者 张燕北 孙晓辉 随 着 A股市场震荡上行,一批主动权益基金净值创出历史新高。 日前, 全市场 超百只 主动 权益基金最新净值创出历史新高,其中,93只基金过去一年涨幅超过50%。 在业内 人士 看来,虽然不确定性仍存,但经过此前 较为 充分的调整,A股市场 值得乐观看 待, 科技成长的布局时点或已临近 。 上百只主动权益基金净值创历史新高 Wind数据显示,截至6月23日,共有106只主动权益基金 ( 仅统计主代码,下同 ) 净值创 出 成立以来 新高 。 从业绩表现来看,这批主动权益基金中,有91只基金年内涨幅超过30%,其中,24只年内涨 幅超过50%,更有10只年内涨幅超过60%,展现出较好的超额收益获取能力。 科技成长布局时点或已临近 展望后市,信达澳亚基金 表示 ,短期来看,市场对于关税担忧减弱,叠加中东局势缓和,市 场进入阶段性风险偏好回升阶段 。 中长期来看,尽管外部环境不确定性仍存,但随着政策红 利逐步释放,以及流动性保持宽裕,有望进一步为A股长期叙事的演绎奠定基础。 "经过此前充分调整,科技成长的布局时点或已临近,科技行业尤其是A ...
年内32只定开基金延长开放期 债基占比超九成
Zheng Quan Ri Bao· 2025-06-24 16:41
近期,部分定期开放型基金(以下简称"定开基金")出现延长开放期的罕见操作。 定开基金是指在特定时间段内开放申购和赎回,其余时间处于封闭期的基金,其核心特征是通过设定固 定的开放期和封闭期进行投资运作。 晨星(中国)基金研究中心总监孙珩在接受《证券日报》记者采访时表示,定开基金的设计初衷是通过 对申赎时间的限制,减少资金频繁进出对基金运作的影响,让基金经理能更专注于中长期投资策略的执 行,从而在一定程度上提升基金在长期投资中的收益稳定性和策略持续性。 "这一现象主要源于债券市场波动加剧及投资者赎回压力上升。为缓解集中赎回带来的流动性冲击或配 合投资策略优化,已有多只定开债券型基金将开放期延长3天至14天不等。"深圳市前海排排网基金销售 有限责任公司公募产品经理朱润康对此分析称,基金管理人通过动态调整产品开放期,在保障投资者申 赎需求与维护基金稳健运作之间寻求平衡,体现出当前市场环境下对风险管理和投资体验的重视。 在债券型基金占主导的开放期调整中,权益类定开基金延长开放期的操作引发市场关注。Wind资讯数 据显示,截至6月24日,平安兴鑫回报一年定期开放混合型证券投资基金年内净值增长率达32.10%,信 澳博见成 ...
3年跑输基准超10%将降薪 哪些基金经理“亮红灯”?
Nan Fang Du Shi Bao· 2025-05-29 23:10
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has released an "Action Plan for Promoting the High-Quality Development of Public Funds," which links fund managers' compensation to long-term performance, addressing the industry's focus on scale over returns [2] Group 1: Fund Manager Compensation - Fund managers with products underperforming their benchmarks by more than 10 percentage points over three years will see a significant decrease in their performance-based compensation [2] - Conversely, fund managers whose performance significantly exceeds benchmarks may see reasonable increases in their compensation [2] Group 2: Underperforming Funds - As of May 21, nearly 6000 public funds have been managed for over three years, with 1341 funds underperforming their benchmarks by over 10 percentage points, involving 735 fund managers [3] - Among these, 31 funds have underperformed their benchmarks by over 50 percentage points, including notable managers like Yao Zhipeng from Harvest Fund and Shi Cheng from Guotai Junan [3] - The worst performer is Morgan Fund's Guo Chen, whose fund has a cumulative return of -23.03%, lagging behind the benchmark by 128 percentage points [3] Group 3: High-Performing Funds - There are 543 funds that have outperformed their benchmarks by over 10 percentage points, with 33 funds exceeding benchmarks by over 50 percentage points [6] - Notable high performers include the Huaxia North Exchange Innovation Small and Medium Enterprises Fund, managed by Guo Xin, which achieved a cumulative return of 194%, surpassing its benchmark by 176 percentage points [6][7] - The North Exchange theme funds have emerged as a concentrated area of excess returns, with several funds exceeding their benchmarks by over 60 percentage points [7] Group 4: Adjustments to Performance Benchmarks - In response to the new action plan, many fund companies have begun to adjust their performance benchmarks, with over 100 funds changing their benchmarks by May 26 [8][10] - Adjustments are made to ensure benchmarks accurately reflect the risk-return characteristics of the funds, addressing previous inadequacies in benchmark design [10][11] - The CSRC emphasizes the need for strict regulation of benchmark selection and modification to ensure alignment with investment strategies and product positioning [11]
新型浮动费率基金力作 交银瑞安正式获批
Zhong Guo Ji Jin Bao· 2025-05-23 11:18
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has officially released the "Action Plan for Promoting the High-Quality Development of Public Funds," which includes 25 systematic reform measures aimed at enhancing the alignment of interests between fund companies and investors [1] Group 1: Action Plan and Fund Management Fee Structure - The Action Plan emphasizes the importance of binding the interests of fund companies with those of investors, proposing a floating management fee model based on performance benchmarks for newly established actively managed equity funds [1] - The floating management fee reform is seen as a significant step towards optimizing actively managed equity funds and transforming the operational model of the fund industry [1] - The new floating fee structure allows management fees to fluctuate based on the annualized return of each fund share and its relative performance against a benchmark, with a maximum increase of 25% and a potential decrease of 50% based on performance [2][3] Group 2: Company Initiatives and Product Development - The company,交银施罗德基金, has actively participated in the floating fee product pilot program, launching the "交银瑞元三年定开基金," which has shown stable performance since its inception [1][2] - The new floating fee fund design aims to align the interests of fund managers and investors, promoting a shared approach to risk and reward, thereby enhancing the overall investment experience [3] - The company is committed to continuous research and development of floating fee funds, focusing on improving market cycle awareness and controlling product volatility to achieve a win-win situation for both the company and investors [3][4] Group 3: Performance and Market Confidence - The company expresses confidence in its ability to discover value and price actively managed equity products, especially in the current favorable market conditions [4] - The management of fund products is characterized by long cycles, requiring a combination of effective design, investment capability, and a rational approach to market fluctuations to create value for investors [4] - The company aims to enhance its asset and wealth management capabilities while maintaining a strong focus on investor interests [4]
北证50创新高,相关基金起飞!年内还有这些产品表现出色,接下来怎么投?
Mei Ri Jing Ji Xin Wen· 2025-05-21 09:17
每经记者|任飞 每经编辑|叶峰 近期,A股市场缩量震荡,题材板块继续快速轮动,而北证50指数则持续走强,创出历史新高。 记者注意到,今年以来,生物医药、人工智能以及北交所等行业及主题基金的表现依然不俗,在年内的净值排行当中,居于前列的产品普遍有此类基金的身 影。 值得注意的是,基金公司也在调整部分产品的申赎政策,近期又有一些基金公告限购方案,如易方达北证50成分指数、东财北证50指数发起等多只基金近期 公告了相关内容。有分析指出,在关注热门行业投资机会的同时,仍需关注外部不确定性带来的风险,并控制加仓节奏。 北证50指数再创新高,基金公司调整限购措施 近期,A股市场板块轮动依然较快,尽管单日上涨家数高于下跌家数的情况多次出现,但个股的赚钱效应却不佳,各宽基指数呈现出震荡走势。然而,北证 50指数却在近期表现活跃。 5月21日,北证50指数低开高走,再次创出历史新高,截至收盘,报收1479.81点。从《每日经济新闻》记者同业内人士交流的情况来看,基于目前北交所个 股量化交易的程度较低,资金仍有继续博弈的可能,不过,这也使得北交所相关主题基金的净值又一次提升。 Wind统计显示,截至5月20日,年内基金的净值收益 ...